Rod Partow-Navid

404 total citations
13 papers, 306 citations indexed

About

Rod Partow-Navid is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Rod Partow-Navid has authored 13 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Surgery. Recurrent topics in Rod Partow-Navid's work include Pulmonary Hypertension Research and Treatments (6 papers), Mitochondrial Function and Pathology (2 papers) and Cardiovascular Function and Risk Factors (2 papers). Rod Partow-Navid is often cited by papers focused on Pulmonary Hypertension Research and Treatments (6 papers), Mitochondrial Function and Pathology (2 papers) and Cardiovascular Function and Risk Factors (2 papers). Rod Partow-Navid collaborates with scholars based in United States and South Korea. Rod Partow-Navid's co-authors include Soban Umar, Mansoureh Eghbali, Andrea Iorga, Salil Sharma, Rangarajan D. Nadadur, Michelle Afkhami, Ji-Youn Youn, Jingyuan Li, Hua Cai and Siamak Rahman and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Rod Partow-Navid

12 papers receiving 302 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rod Partow-Navid United States 8 130 119 64 59 56 13 306
Jon Offstad Norway 12 237 1.8× 91 0.8× 41 0.6× 79 1.3× 67 1.2× 25 372
Ying Tung Sia Canada 9 259 2.0× 75 0.6× 68 1.1× 91 1.5× 68 1.2× 21 387
Sarah Triem Germany 3 44 0.3× 33 0.3× 67 1.0× 51 0.9× 20 0.4× 3 315
Eva Gonçalvesová Slovakia 12 289 2.2× 59 0.5× 193 3.0× 66 1.1× 44 0.8× 54 512
Olaf Richter Germany 5 52 0.4× 117 1.0× 56 0.9× 169 2.9× 27 0.5× 11 346
Katerina Koniari Greece 10 78 0.6× 33 0.3× 80 1.3× 56 0.9× 35 0.6× 12 309
Sheldon Y. Freeberg United States 6 107 0.8× 25 0.2× 107 1.7× 95 1.6× 74 1.3× 7 363
Konstantinos Siogas Greece 10 216 1.7× 40 0.3× 49 0.8× 50 0.8× 30 0.5× 14 325
Zongtao Yin China 13 227 1.7× 65 0.5× 88 1.4× 44 0.7× 45 0.8× 30 395
Shuji Mukae Japan 9 133 1.0× 48 0.4× 84 1.3× 11 0.2× 27 0.5× 14 306

Countries citing papers authored by Rod Partow-Navid

Since Specialization
Citations

This map shows the geographic impact of Rod Partow-Navid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rod Partow-Navid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rod Partow-Navid more than expected).

Fields of papers citing papers by Rod Partow-Navid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rod Partow-Navid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rod Partow-Navid. The network helps show where Rod Partow-Navid may publish in the future.

Co-authorship network of co-authors of Rod Partow-Navid

This figure shows the co-authorship network connecting the top 25 collaborators of Rod Partow-Navid. A scholar is included among the top collaborators of Rod Partow-Navid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rod Partow-Navid. Rod Partow-Navid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Partow-Navid, Rod, et al.. (2021). Role of Guideline Directed Medical Therapy Doses and Optimization in Patients Hospitalized With Decompensated Systolic Heart Failure. The American Journal of Cardiology. 151. 64–69. 7 indexed citations
2.
Partow-Navid, Rod, et al.. (2021). ACUTE THROMBOCYTOPENIA IN A PATIENT WITH LEFT ANTERIOR DESCENDING ARTERY ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION. Journal of the American College of Cardiology. 77(18). 2536–2536.
3.
Partow-Navid, Rod, et al.. (2021). POST-ACUTE PULMONARY EMBOLISM IN COVID-19 PNEUMONIA. Journal of the American College of Cardiology. 77(18). 2796–2796. 1 indexed citations
4.
Partow-Navid, Rod, et al.. (2021). Management of ST Elevation Myocardial Infarction (STEMI) in Different Settings. International Journal of Angiology. 30(1). 67–75. 8 indexed citations
5.
Umar, Soban, Rod Partow-Navid, Grégoire Ruffenach, et al.. (2017). Severe pulmonary hypertension in aging female apolipoprotein E-deficient mice is rescued by estrogen replacement therapy. Biology of Sex Differences. 8(1). 9–9. 9 indexed citations
6.
Li, Jingyuan, Andrea Iorga, Salil Sharma, et al.. (2012). Intralipid, a Clinically Safe Compound, Protects the Heart Against Ischemia-Reperfusion Injury More Efficiently Than Cyclosporine-A. Anesthesiology. 117(4). 836–846. 59 indexed citations
7.
Nadadur, Rangarajan D., et al.. (2012). Reverse right ventricular structural and extracellular matrix remodeling by estrogen in severe pulmonary hypertension. Journal of Applied Physiology. 113(1). 149–158. 53 indexed citations
8.
Iorga, Andrea, Shannamar Dewey, Rod Partow-Navid, Aldrin V. Gomes, & Mansoureh Eghbali. (2012). Pregnancy Is Associated with Decreased Cardiac Proteasome Activity and Oxidative Stress in Mice. PLoS ONE. 7(11). e48601–e48601. 20 indexed citations
9.
Umar, Soban, Rangarajan D. Nadadur, Salil Sharma, et al.. (2012). Genistein, a Soy Phytoestrogen, Reverses Severe Pulmonary Hypertension and Prevents Right Heart Failure in Rats. Hypertension. 60(2). 425–430. 73 indexed citations
10.
Kumarasamy, Sivarajan, et al.. (2012). Construction of two novel reciprocal conplastic rat strains and characterization of cardiac mitochondria. American Journal of Physiology-Heart and Circulatory Physiology. 304(1). H22–H32. 22 indexed citations
11.
Umar, Soban, Rangarajan D. Nadadur, Rod Partow-Navid, et al.. (2011). Complete Reversal Of Cardiac And Pulmonary Remodelling Associated With Severe Pulmonary Arterial Hypertension By Estrogen Therapy. A2522–A2522. 1 indexed citations
12.
Umar, Soban, Enno de Lange, Andrea Iorga, et al.. (2011). Spontaneous Ventricular Fibrillation in Right Ventricular Failure Secondary to Chronic Pulmonary Hypertension. Circulation Arrhythmia and Electrophysiology. 5(1). 181–190. 52 indexed citations
13.
Umar, Soban, et al.. (2010). Abstract 18969: Estrogen Rescues Severe Pulmonary Hypertension and Increases Survival Through Stimulation of Neoangiogenesis and Suppression of Inflammation. Circulation. 122. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026